Single-Cell Transcriptomic Identification of CAMK2A as a Therapeutic Target in Human Trigeminal Ganglion Nociceptors for Migraine Treatment

Read full text Summarise with VIRAT
Authors: Glen Charles Ritschel, Claude
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Migraine is a debilitating primary headache disorder with substantial unmet therapeutic need. Here we apply a computational drug screening pipeline to the human trigeminal ganglion (TG) snRNA-seq atlas GSE197289 (36,154 nuclei, 3 donors; Yang et al., Neuron 2022) to identify CAMK2A (calcium/calmodulin-dependent protein kinase II alpha) as a high-priority druggable target in migraine-signature-positive nociceptor clusters. ScVI dimensionality reduction and Leiden clustering identified 16 TG cell populations; a 22-gene migraine nociceptor signature identified clusters 14, 8, and 12 as CGRP-positive nociceptor subpopulations. Wilcoxon differential expression yielded 5,530 upregulated genes. ChEMBL drug screening against neurologically-filtered targets identified 62 NOVEL_ALL CAMK2A inhibitor candidates, all patent-clear for the migraine/trigeminal indication. Lead compounds include midostaurin (FDA-approved, pChEMBL 7.70), lestaurtinib (CAMK2A+TrkA/TrkB, pChEMBL 8.00), and CHEMBL573578 (pChEMBL 8.10). CAMK2A co-upregulation with SCN10A (Nav1.8) and GRIA1 (GluA1) in migraine-priority clusters supports a convergent nociceptor hyperexcitability mechanism. A provisional patent application has been filed (USPTO App. No. 64/013,194). Pipeline: github.com/glenritschel/migraine-tg-scrna. Provisional spec: https://doi.org/10.5281/zenodo.19165974

Fields of Study & Subjects

Migraine and Headache Studies Pain Mechanisms and Treatments Computational Drug Discovery Methods

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
22 March 2026
Language
EN
Document type
Preprint